Nutraceutical Targeting of Placental Synthesis of Soluble Fms-Like Tyrosine Kinase- 1 (sFlt-1) as Strategy for Preventing and Controlling Pre-eclampsia

By  

Current Pharmaceutical Design, Vol. 24, Iss. 20, 2018-06 ,pp. : 2255-2263

Bentham Science Publishers

Access to resources Recommend Favorite

FMS-like tyrosine kinase 3 inhibitors: a patent review

By Lee Jongkook   Paek Seung-Mann   Han Sun-Young  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 483-503

Informa Healthcare

Access to resources Recommend Favorite

Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia

By Prescott Hillary   Kantarjian Hagop   Cortes Jorge   Ravandi Farhad  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 407-423

Informa Healthcare

Access to resources Recommend Favorite

Recent Advancements in Small Molecule Inhibitors of Insulin–like Growth Factor-1 Receptor (IGF-1R) Tyrosine Kinase as Anticancer agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 5, 2013-04 ,pp. : 653-681

Bentham Science Publishers

Access to resources Recommend Favorite

Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1

By Winum Jean-Yves  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 757-760

Informa Healthcare

Access to resources Recommend Favorite